ZUSAMMENSETZUNG FUER TRANSDERMALE THERAPEUTISCHE SYSTEME VON SCHLEIFENDIURETIKA

There is described a composition for transdermal therapeutic systems which contain, as active substance, furosemid, piretanid or lemidosul or a physiologically acceptable salt of these loop diuretics in a base consisting of a fatty acid alkanolamide or a mixture of fatty acid alkanolamides having 8-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PETRI,WALTER,DR, REUL,BERNHARD, HROPOT,MAX,DR
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is described a composition for transdermal therapeutic systems which contain, as active substance, furosemid, piretanid or lemidosul or a physiologically acceptable salt of these loop diuretics in a base consisting of a fatty acid alkanolamide or a mixture of fatty acid alkanolamides having 8-18 carbon atoms in the fatty acid moiety and 2 to 6 carbon atoms and 1 to 3 hydroxyl groups in the alkanolamide moiety and, if appropriate, a carboxylic ester or a mixture of carboxylic esters having in each case 1-22 carbon atoms in the carboxylic acid moiety and 1-22 carbon atoms in the alcohol moiety.